A common methodology is reported for the determination of five major anticonvulsants (carbamazepine, ethosuximide, phenobarbital, phenytoin, primidone) and their active metabolites (carbamazepine-10,11-epoxide, phenylethylmalonamide) in 30 of plasma. After a single step of deproteinisation and extraction with acetonitrile, leading to an almost complete recovery of all the analytes, 5 is injected on a reversed-phase column 5 ). The anticonvulsants are eluted isocratically at a column temperature of 50 °C with a mobile phase consisting of acetonitrile/phosphate buffer pH 6.9 (40/60 by vol), and monitored at 208 nm. Quantitäten, using peak height or peak area, is based on the ratio of analyte to internal Standard (allylisobutylbarbital) referenced to a serum-based multiple drug Standard. The composition and pH of the mobile phase, temperature of the column, choice of wavelength of detection and size of the column material äre cruäal for the optimal Separation of these five drugs and their two active metabolites in a Chromatographie time of only 12 min, without sacrificing high sensitivity and column life. Carbamazepin, Ethosuximid, Phenobarbital, Phenytoin, Primidon und 
Neels, , Verkerk, Vlietinck and Scharpo: 'HPLC of anticonvulsants in plasma
Usually several components in a mixture must be analysed. Immunological methods are less convenient because separate analyses must be performed for each drug, and cross-reactivity may also occur. Chromatographie methods guarantee greater selectivity and they have the advantage of rapid and simple Operation. A preliminary extraction of relatively large quantities of biological material is inevitable when the GLC method is used, which pleads in favour of HPLC methods.
Several HPLC methods have recently been reported for the analysis of anticonvulsant drugs, applied either to the assay of one specific anticonvulsant (1-4), or to the simultaneous determination of several anticonvulsants (5) (6) (7) (8) (9) (10) (11) .
In an attempt to select a convenient method for the therapeutic monitoring in plasma of mixtures of the common anticonvulsants, ethosuximide, carbamazepine, phenobarbital, phenytoin, primidone and their active metabolites (phenylethylmalonamide, carbamäzepine-10,ll-epoxide), we have evaluated several high-performance liquid Chromatographie methods in our daily routine during a period of three years. In our hands, various recently developed procedures (6, 9, 11) are appropriate, but we propose several modifications with emphasis on simultaneous determination of active metabolites, easy Operation, short Chromatographie time, high sensitivity, long column life, and low cost.
Materials and Methods

Apparatus
We used a high performance liquid Chromatographie System (Wa- For the solvent precipitation of the serum proteins we used a microcentrifuge, Model Select-a-Fuge 24, obtained from the Allen Medical Instrument Division, Bio-Dynamics Inc., Santa Ana, CA U.S.A.
Reagents and Standards
All chemicals used were of reagent grade. Distilled water was used throughout.
Mobile phose buffer: this is a degassed solution of 40 ml of acetonitrile (Gold label, Aldrich, Beerse, Belgium) in 60 ml of phosphate buffer (pH 6.9). 
Procedure
Add 30 of acetonitrile containing 750 ng of allylisobutylbarbital (äs an internal Standard) to 30 of serum or plasma in an Epperidorf 1.5 ml polypropylene microtube. Vortex, mix the mixture for 10s, then centrifuge ät 8000 min" 1 (5400g) for 5min. Inject about 5 ] of the supernate directly onto the column and elute with the mobile phase at a flow rate of 0.8 ml/min (pressure: 1000 psi) and a column temperature of 50 °C. With deteriorating columns, however, a better Separation can be achieved at a flow rate of 0.6 ml/min (pressure: 800 psi) arid a cpluriin temperature of 30 °C. The UV absorption is registered at 208 nm at a sensitivl· ty setting of 0.04 A füll scale. Concentrations of phenobarbital higher than 25 mg/1 were measured at 0.1 A füll scale.
Results
We evaluated several Chromatographie cönditions based on the procedures described by Soldifi etal. column. By extending the column length to 600 mm, fifteen anticonvulsants may be separated using the cönditions reported in the fprmer method. A § both the analysis time and the high pressure made the method less applicable for routine analysis, we decided to determine the optimal analytical variables for a simultaneous analysis of five common anticonvulsants and two active metabolites using the aforementioned 300 rnm colüöin.
Optimum cönditions
The composition of the mobile phase, the pH of the mobile phase and the temperature of the coliimn were varied to obtain optimal Chromatographie cön-ditions. The most satisfäctory Separation of phenylethylmalonamide, primidone, ethosuximide and phenobarbital from serum components e. g. creatinine and uric acid was obtained at roöm temperäture when the pH of the phosphate buffer componerit of the eluent was äböut 6.9, and the ratio of the buffer to acetonitrile was 60:40 by Volume.
Iricreäsing the temperature to 50 °C provided an adequate Separation öf phenytoin and carbamazepine with acceptable loss of resolutibn between ethosuximide and primidone. Lowering the tempefature below 40 °C resulted not only in a loss of resolution of carbamazepine and phenytoin but also in longer retention times. The preferred temperature J. Clin. Chem.. Clin. Biochem. / Vol. 21,1983 / No. 5 was therefore 50 °C. A.flow rate of 0.8 ml/min for the mobile phase resulted in an analysis time of 12min at 50 °C ( fig. 1 ).
Using this conditions we can inject 400 samples of 5 deproteinised serum without loss of resolution or peak broadening. 
UV-detection
A detector wavelength of 208 nm was chosen after careful study of the UV-spectra of the anticonvulsants at their therapeutic and subtherapeutic concentrations ( fig. 2) . Although it has been reported that the sensitivity of determination of carbamazepine-10,11-epoxide is 1/15 of that of carbamazepine at 254 nm (1), this metabolite was easily detected in the nanogram ränge at 208 nm; this was achieved with an improved UV-detection, using ä variable wavelength spectrophotometer, equipped with a time constant and heat exchanger, which substantially reduce the instrumental noise.
For the 5 sample, the detection limit of the drugs examined is less than l mg/1 (ränge 0.3 to 0.9 mg/1), except for ethosuximide for which the detection limit is 3 mg/1.
Quantitation
The chromatogram was quantitated by measuring the ratio of drug to internal Standard, based on peak height or peak area. Both methods were quite satis- factory for this analysis. In every single nm a serumfree Standard of anticonvulsants and metabolites is run with an appropriate eontrol serum in order to monitor retention times and to cälculate relative response factors.
The investigation of linearity was carried out in the ränge of 1-50 mg/1, except for ethosuximide (1^200 mg/1). The resülts showed good linearity in this ränge.
Precision
The precision of the method was assessed by repeat-. ed analysis of pooled sera containing a Standard mixture of the drügs and the active metabolites being investigated. As shown in table l, within day precision varied between 2.3% and 6.8%, day-to-day precision between 3.2% and 7.9%.
Recovery
The recovery from serum was checked by spiking a drug-free serum with five different concentrations of anticonvulsant drugs and active metabolites. Resülts were expressed äs fractions of the peak heights obtained by the direct injection of the serum-free Standards. As shown in table 2, absolute recoveries of the drugs ränge from 0.93 to 1.03, whereas absolute recoveries of the active metabolites varied from 0.91 to 1.07. Potential interference by currently described drugs was investigated by chromatographing each drug. Table 3 lists the relative retention time of the cofiiponents tested. The retention time ,<pf the internal Standard allylisobutylbarbital was assigned a value of 100. Good practice in drug monitoring iiivolves the availability to the labpratory of complete Information about the medication taken by the patient. As can be seen from table 3 some co-elutions cannot be ex- In these and our procedure, the sera are deproteinised by adding an equal amount of acetonitrile to the samples, followed by centrifugation in polypropylene tubes at a relative high centrifugal force to obtain a complete precipitation of serum proteins. In order to extend the useful life of the column we prefer to inject a small sample volume (5 μΐ) instead of 20 μΐ (8, 9) .
In his first method Soldin et al. (6) described the use of a mobile phase consisting of an equivolume mixture of potassium phosphate buffer (pH = 8.0) and acetonitrile, which resulted in a serious deterioration of the column packing material due to the alkaline pH of the eluent.
The mobile phase of their new System (11), consisting of phosphate buffer (pH = 6.7) and acetonitrile (52.5/47.5 by volume), guarantees a longer column life, but in both methods the primidone metabolite phenylethylmalonamide interferes with the analysis of primidone, which results in falsely elevated levels of primidone. The use of a pH 4.4 phosphate buffer, however, which is proposed by Kabra et al. (8) necessitated the restriction of the ratio of acetonitrile/ phosphate buffer to about 20/80 parts by vol. in order to obtain a good Separation between ethosuximide, primidone and phenylethylmalonamide. Furthermore, using these conditions, a pressure of 11 MPa (1600 psi) had to be maintained, resulting in a flow rate of 3.0 ml/min, in order to restrict the analysis time to about 14 min at an Optimum column temperature of 50 °C. To resolve also the active metabolite of carbamazepine, carbamazepine-10,11 -epoxide, and to make the method more suitable for routine analysis, we propose that the anticonvulsants be eluted with a mobile phase consisting of acetonitrile/phosphate buffer (pH 6.9) (40/60 by vol) at a flow-rate of 0.8 ml/min (1000 psi) and a column tempefature of 50 °C; this requires only 12 min for completion. Further we monitor the column effluent at 208 nm rather than at 195 nm, not only because of the absorption maxima of the anticonvulsants but also to prolong the useful life of the UV-lamp of the detector. Finally we propose that the 10 μηι smallparticle column material be replaced by 5 μπι particles to increase column efficiently.
